Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues

Until now, the Food and Drug Administration (FDA)-approved iron supplement ferumoxytol and other iron oxide nanoparticles have been used for treating iron deficiency, as contrast agents for magnetic resonance imaging and as drug carriers. Here, we show an intrinsic therapeutic effect of ferumoxytol...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Nanotechnol
Main Authors: Zanganeh, Saeid, Hutter, Gregor, Spitler, Ryan, Lenkov, Olga, Mahmoudi, Morteza, Shaw, Aubie, Pajarinen, Jukka Sakari, Nejadnik, Hossein, Goodman, Stuart, Moseley, Michael, Coussens, Lisa Marie, Daldrup-Link, Heike Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5198777/
https://ncbi.nlm.nih.gov/pubmed/27668795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nnano.2016.168
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares